Autopsy report · NCT02740699
CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction
Cause of deathStaffing, sites or logistics
“Principal Investigator resigned and closed program”
Life of this trial
- Ran for about 5 years 11 months before it stopped.
- 79 participants enrolled.
- Results were posted on the registry 2 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Cardiovascular Disease
- Interventions
- Rosuvastatin; Atorvastatin; Cardiac Computed Tomography (CT); Cardiac Magnetic Resonance Image (MRI)
- Participants
- 79
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
“Resignation of Principal Investigator” - Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery
“Principal investigator left the institution” - Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
“Principal Investigator has left the institution” - Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy
“Principal Investigator left the institution requested termination” - Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
“the Principal Investigator left the institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.